Compounds > 3-hydroxy-3-methylglutaryl-coenzyme a

3-hydroxy-3-methylglutaryl-coenzyme a and Coronary Disease

3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Coronary Disease in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (50.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Igel, M; Sudhop, T; von Bergmann, K	1
Tobert, JA	1
Parhofer, KG; Richter, WO; Schwandt, P	1
Ballantyne, CM; el Masri, B; Morrisett, JD; Torre-Amione, G	1
Kellett, J	1
Jacobson, TA	1
Beatt, KJ; Khan, M; Malik, IS	1

Reviews

4 review(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Coronary Disease

Article	Year
Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin. Journal of clinical pharmacology, 2002, Volume: 42, Issue:8 Topics: Acyl Coenzyme A; Coronary Disease; Enzyme Inhibitors; Fluorobenzenes; Hypolipidemic Agents; Pyrimidines; Quinolines; Rosuvastatin Calcium; Sulfonamides	2002
Drug therapy of severe hypercholesterolemia in patients with coronary artery disease. Artificial organs, 1996, Volume: 20, Issue:4 Topics: Acyl Coenzyme A; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol, LDL; Coronary Disease; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; Humans; Hypercholesterolemia; Hypolipidemic Agents; Triglycerides	1996
Pathophysiology and treatment of lipid perturbation after cardiac transplantation. Current opinion in cardiology, 1997, Volume: 12, Issue:2 Topics: Acyl Coenzyme A; Animals; Blood Component Removal; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Immunosuppressive Agents; Lipoproteins; Tacrolimus	1997
"The lower the better" in hypercholesterolemia therapy: a reliable clinical guideline?. Annals of internal medicine, 2000, Oct-03, Volume: 133, Issue:7 Topics: Acyl Coenzyme A; Anticholesteremic Agents; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Humans; Hypercholesterolemia; Lovastatin; Practice Guidelines as Topic; Risk Factors; Simvastatin	2000

Other Studies

4 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Coronary Disease

Article	Year
[Significance of HDL cholesterol increase for the risk reduction. Methods of intervention. recommendations of experts]. Kardiologia polska, 2005, Volume: 62 Suppl 2 Topics: Acyl Coenzyme A; Adult; Anticholesteremic Agents; Cholesterol, HDL; Clofibric Acid; Coronary Disease; Europe; Female; Humans; Male; Niacin; Practice Guidelines as Topic; Risk Factors; Risk Reduction Behavior; Societies, Medical	2005
Blood cholesterol measurement in young adults. JAMA, 1993, Aug-25, Volume: 270, Issue:8 Topics: Acyl Coenzyme A; Cholesterol; Coronary Disease; Humans; Hypolipidemic Agents	1993
Likely gains in life expectancy of patients with coronary artery disease treated with HMG-CoA reductase inhibitors, as predicted by a decision analysis model. The European journal of surgery = Acta chirurgica, 1997, Volume: 163, Issue:7 Topics: Acyl Coenzyme A; Adult; Age Distribution; Aged; Aged, 80 and over; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Decision Support Techniques; Female; Humans; Life Expectancy; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Rate	1997
Effect of statin therapy on restenosis after coronary stent implantation. The American journal of cardiology, 2000, Oct-01, Volume: 86, Issue:7 Topics: Acyl Coenzyme A; Cholesterol, LDL; Coronary Disease; Humans; Muscle, Smooth, Vascular; Recurrence; Stents	2000